SLC30A9 antibody
| Product name: | SLC30A9 antibody |
| Source: | Rabbit |
| Purity: | >95% |
| Buffer Formulation: | phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
| Applications: | WB IHC |
| Storage: | Aliquot and store at -20°C. Avoid repeated freeze / thaw cycles |
| UOM: | 100ug |
Rabbit anti-SLC30A9 polyclonal antibody - N-terminal region
Catalog Number:IC105355
Product Profile
| ProductName | Rabbit anti-SLC30A9 polyclonal antibody - N-terminal region |
|---|---|
| AntibodyType | Primary Antibodies |
| Immunogen |
The immunogen for anti-SLC30A9 antibody: synthetic peptide directed towards the N terminal of human SLC30A9 |
Key Feature
| Clonality | Polyclonal |
|---|---|
| Isotype | IgG |
| Host Species | Rabbit |
| Tested Applications | |
| Species Reactivity | |
| Concentration | 1mg/ml |
| Purification | Affinity purified |
Target Information
| Gene Symbol | SLC30A9 |
|---|---|
| Gene Synonyms |
HUEL
More
ZNT9 GAC63 C4orf1 |
| Gene Full Name | Solute carrier family 30 (zinc transporter), member 9 |
| Gene Summary |
The gene corresponding to embryonic lung protein [also known as Solute carrier family 30 (Zinc transporter), member 9, SLC30A9], is likely to be an evolutionarily conserved, housekeeping gene that plays a role intimately linked with cellular replication, DNA synthesis and/or transcriptional regulation.
More
|
| Alternative Names |
HUEL
More
ZNT9 GAC63 C4orf1 |
| MolecularWeight(MW) | 63kDa |
| Sequence | 568 amino acids |
Database Links
| Entrez Gene | 10463 |
|---|---|
| SwissProt ID | Q9Y6R2 |
| Protein Accession | NP_006336 |
Application
-
Immunohistochemical
-
Western blot
0.2-1 ug/ml
ELISA Titer: 1:62500
Positive Control: HepG2 cell lysate
Additional Information
| Form | Liquid |
|---|---|
| Storage Instructions | Aliquot and store at -20°C. Avoid repeated freeze / thaw cycles |
| Storage Buffer | phosphate buffered saline , pH 7.4, 150mM NaCl, 0.02% sodium azide and 50% glycerol. |
Note: The product is for research use only,not for use in diagnostic or therapeutic procedures.
|
|












